Search research articles
Contact Us
Filters
Showing results (831-840 of 851) with videos related to
Page
of 86
Sort By:
Nature Communications
|
October 24, 2025
Addressing data heterogeneity in distributed medical imaging with heterosync learning
Hang-Tong Hu, Ming-De Li, Xin-Xin Lin, et al.
The Biochemical Journal
|
November 9, 2005
Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma
Bao-Liang Song, Can-Hua Wang, Xiao-Min Yao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|
March 27, 2025
Impact of compliance to postoperative regular follow-up on long-term prognosis after curative resection for hepatocellular carcinoma: A multicenter analysis
Lan-Qing Yao, Jin-Bo Gong, Lei Cai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 24, 2014
Modification of chemokine receptor expression to enhance levels of trafficking receptors on autologous cytokine-induced killer cells derived from patients with colorectal cancer
Dan Wang, Jing Li, Jin-Yan Liu, et al.
Signal Transduction and Targeted Therapy
|
February 24, 2021
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota
Yan Wang, Qian Tong, Shu-Rong Ma, et al.
World Journal of Gastroenterology
|
March 29, 2017
Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer
Jin-Bo Lin, Lei Zhang, Dong-Wen Wu, et al.
Lancet (London, England)
|
May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.
Annals of Surgical Oncology
|
April 5, 2025
Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model
Yi-Fan Li, Lan-Qing Yao, Chao Li, et al.
The Lancet. Respiratory Medicine
|
May 20, 2023
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study
Tao Huang, Sheng Zhang, De-Fang Dai, et al.
The Lancet. Respiratory Medicine
|
March 10, 2023
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
Rong Tang, Hui Zheng, Bu-Sen Wang, et al.
Page
of 86
Search research articles
Search
Showing results (831-840 of 851) with videos related to
Sort By:
Page
of 86
Nature Communications
|
October 24, 2025
Addressing data heterogeneity in distributed medical imaging with heterosync learning
Hang-Tong Hu, Ming-De Li, Xin-Xin Lin, et al.
The Biochemical Journal
|
November 9, 2005
Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma
Bao-Liang Song, Can-Hua Wang, Xiao-Min Yao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|
March 27, 2025
Impact of compliance to postoperative regular follow-up on long-term prognosis after curative resection for hepatocellular carcinoma: A multicenter analysis
Lan-Qing Yao, Jin-Bo Gong, Lei Cai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 24, 2014
Modification of chemokine receptor expression to enhance levels of trafficking receptors on autologous cytokine-induced killer cells derived from patients with colorectal cancer
Dan Wang, Jing Li, Jin-Yan Liu, et al.
Signal Transduction and Targeted Therapy
|
February 24, 2021
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota
Yan Wang, Qian Tong, Shu-Rong Ma, et al.
World Journal of Gastroenterology
|
March 29, 2017
Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer
Jin-Bo Lin, Lei Zhang, Dong-Wen Wu, et al.
Lancet (London, England)
|
May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.
Annals of Surgical Oncology
|
April 5, 2025
Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model
Yi-Fan Li, Lan-Qing Yao, Chao Li, et al.
The Lancet. Respiratory Medicine
|
May 20, 2023
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study
Tao Huang, Sheng Zhang, De-Fang Dai, et al.
The Lancet. Respiratory Medicine
|
March 10, 2023
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
Rong Tang, Hui Zheng, Bu-Sen Wang, et al.
Page
of 86